Dermatology

Adolescent isotretinoin use was not linked to reduced adult height in a major Danish study. Learn more about the findings in acne treatment.

A 6-month text-messaging programme improved cardiovascular risk self-management in adults with psoriasis in a randomised trial.

Combining ixekizumab with tirzepatide improved skin clearance and weight loss in adults with psoriasis and obesity in a Phase 3b trial.

New trial data show dupilumab improves itch, skin healing and quality of life in patients with prurigo nodularis, even without optimal response.

English registry data show lentigo maligna has only a 1% risk of progression to invasive melanoma over 10 years.

Tildrakizumab showed sustained efficacy and safety in moderate-to-severe scalp psoriasis, regardless of obesity status, over 52 weeks.

A real-world study found tildrakizumab improved skin clearance, symptoms, and quality of life in adults with plaque psoriasis.

A large BADBIR study assesses serious infection risk across psoriasis systemic treatments, highlighting largely similar safety profiles with some treatment-specific signals.